Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.16.3.1 (
ceruloplasmin
)
5,074
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It is known that human
ceruloplasmin
(CP) is made up of several isoforms which differ by the structure of their carbohydrate fragment. One of these isoforms,
CP1
, which makes up to approximately 40% of the native CP molecule and which contains a carbohydrate fragment, [formula: see text] is specifically bound to human erythrocyte (ER) receptors. This isoform was isolated by using lectin affinity chromatography. It was found that
CP1
produces a much stronger protective effect on ER during Cu(2+)-induced lysis as compared with CP. A kinetic analysis of Cu2+ accumulation and reduced glutathione (GSH) decline in ER revealed that the lack of correlation between these two processes. It was found that in the presence of CP and
CP1
the GSH concentration is not critical for the hemolytic resistance of ER. In the presence of
CP1
ER hemolysis occurs at a slower rate whereas the GSH decline at a much faster rate than in the presence of CP.
...
PMID:[Protective effect of various forms of human ceruloplasmin in copper-induced erythrocyte lysis]. 165 69
The comparison of protective effects of native
ceruloplasmin
(CP) and of preparation
CP1
containing carbohydrate fragment GlcNAc(beta(1,4]GlcNAc which specifically binds on RBC (alpha(1,6)Fuc receptors showed that
CP1
exhibits much more powerful protective effect on RBC in copper-induced lysis. It was found, however, that CP2 (native CP devoided of
CP1
) protected RBC as well as CP despite its inability of binding to RBC membrane. CP and
CP1
in a similar way decrease copper concentration in RBC. It was shown that copper accumulation and GSH decrease in RBC are two independent and concurrent processes; the copper and GSH concentrations are not the factors determining RBC resistance to hemolysis. CP inhibits the reaction of superoxide radicals generation as a result of Cu interaction with -SH groups of RBC membrane; the effect is more pronounced than the effect of catalase or superoxide dismutase. CP and
CP1
preparations equally inhibit this reaction. Apparently CP reception on RBC leads not only to membrane protection from superoxide and hydroxyl radicals but represents a more complex process.
...
PMID:The protective effect of different forms of human ceruloplasmin in copper-induced lysis of red blood cells. 228 81
Copper ions of different types were gradually eliminated from
ceruloplasmin
(
CP1
; ferro-O2-oxidoreductase,
EC 1.16.3.1
.) by dialyzing the enzyme against KCN. Protein was sampled 2, 4, 6, 22, and 28 h after the dialysis started. Atomic absorption allowed us to estimate the amount of copper atoms per CP molecule. Light absorption in the UV and visible regions along with fluorescence and EPR spectra were also registered. Oxidase and dismutase activities of the enzyme were measured at each step. The combination of the data thus obtained allowed us to trace the sequence of CP depletion of certain copper ions. The same methods were applied in reconstitution studies to detect the return of different types of Cu2+. The experiments were performed on CP samples differing in the amount of copper still bound after CN- treatment. It is shown that the oxidase activity is efficiently brought back to CP if, after the dialysis against cyanide, the catalytic center had preserved its type 3 Cu2+. Dismutase activity of CP did not depend greatly on the presence or absence of type 1 and type 2 copper ions. The results obtained allow a more precise evaluation of the role of different types Cu2+ in the assembly of the complex catalytic center of CP and in the accomplishment by the enzyme of its multiple functions.
...
PMID:Copper depletion/repletion of human ceruloplasmin is followed by the changes in its spectral features and functional properties. 902 69